BioNeutra Global Corporation
BGACFOTCConsumer Defensive● Active
$0.01
+$0.00(+0.00%)
Market Cap$260113
P/E Ratio—
52W High$0.067
52W Low$0.0056
BioNeutra Global Corporation（BGACF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BGACF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $11.38M | $13.39M | $15.40M | $24.12M | $37.70M |
| Cost of Revenue | $7.24M | $11.04M | $12.51M | $20.17M | $37.06M |
| Gross Profit | $4.14M | $2.35M | $2.89M | $3.94M | $0.64M |
| Gross Margin %(computed) | 36.40% | 17.53% | 18.77% | 16.35% | 1.69% |
| Operating Expenses | |||||
| R&D Expenses | $0.15M | ($0.02M) | $0.01M | $0.26M | $0.44M |
| G&A Expenses | $3.73M | $3.78M | $3.73M | $3.96M | $8.38M |
| Total Operating Expenses | $5.58M | $4.82M | $5.25M | $6.97M | $8.58M |
| Operating Income | ($1.44M) | ($2.42M) | ($2.35M) | ($3.03M) | ($9.83M) |
| Operating Margin %(computed) | -12.63% | -18.06% | -15.29% | -12.55% | -26.08% |
| Interest Income | $0.12M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.70M | $0.45M | $0.39M | $0.43M | $0.60M |
| Income Before Tax | ($2.11M) | ($2.92M) | ($2.83M) | ($3.77M) | ($13.02M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | ($0.06M) | ($0.58M) |
| Net Income | ($2.11M) | ($2.92M) | ($2.83M) | ($3.71M) | ($12.44M) |
| Net Margin %(computed) | -18.52% | -21.81% | -18.38% | -15.37% | -33.00% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.05 | $-0.06 | $-0.06 | $-0.08 | $-0.27 |
| Wtd Avg Shares | 46.45M | 46.45M | 46.45M | 46.45M | 46.45M |
| EBITDA | ($0.35M) | ($1.36M) | ($1.11M) | ($1.50M) | ($10.10M) |
| EBITDA Margin %(computed) | -3.09% | -10.16% | -7.24% | -6.21% | -26.79% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · CAD · M
深入了解BioNeutra Global Corporation
关于BioNeutra Global Corporation（BGACF）损益表
BioNeutra Global Corporation（BGACF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2023财年，BGACF实现营收$0.01B，毛利润$0.00B（毛利率36.40%），净利润($0.00B)（净利率-18.52%）。
常见问题
BGACF · 4 问BioNeutra Global Corporation（BGACF）2023财年营收为$0.01B，同比down15.0%。
BGACF revenueBGACF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09